WO2020046543A3 - Complexes tétrapyrrole solubles dans l'eau contenant des ligands de biladiène utiles en thérapie photodynamique - Google Patents
Complexes tétrapyrrole solubles dans l'eau contenant des ligands de biladiène utiles en thérapie photodynamique Download PDFInfo
- Publication number
- WO2020046543A3 WO2020046543A3 PCT/US2019/045250 US2019045250W WO2020046543A3 WO 2020046543 A3 WO2020046543 A3 WO 2020046543A3 US 2019045250 W US2019045250 W US 2019045250W WO 2020046543 A3 WO2020046543 A3 WO 2020046543A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water soluble
- photodynamic therapy
- tetrapyrrole
- biladiene
- complexes containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/006—Palladium compounds
- C07F15/0066—Palladium compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Les complexes de tétrapyrrole de métaux solubles dans l'eau sont utiles en thérapie photodynamique, les complexes étant capables de fonctionner en tant que photosensibilisateurs qui, activés par la lumière, conduisent à la génération d'oxygène singulet. L'oxygène singulet ainsi produit est toxique pour les cellules cancéreuses. Les ligands de tétrapyrrole présents dans ces complexes sont caractérisés par la présence d'au moins un segment de solubilisation dans l'eau (qui peut être présenté, par exemple, sous la forme d'un poly (oxyalkylène) contenant un substituant), ce qui aide à favoriser la biocompatibilité du complexe.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862714856P | 2018-08-06 | 2018-08-06 | |
| US62/714,856 | 2018-08-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2020046543A2 WO2020046543A2 (fr) | 2020-03-05 |
| WO2020046543A3 true WO2020046543A3 (fr) | 2020-05-14 |
Family
ID=69643971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2019/045250 Ceased WO2020046543A2 (fr) | 2018-08-06 | 2019-08-06 | Complexes tétrapyrrole solubles dans l'eau contenant des ligands de biladiène utiles en thérapie photodynamique |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2020046543A2 (fr) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040186285A1 (en) * | 2003-03-21 | 2004-09-23 | Ceramoptec Industries, Inc. | Water-soluble mono-PEGylated tetrapyrrole derivatives for photodynamic therapy and method of production |
-
2019
- 2019-08-06 WO PCT/US2019/045250 patent/WO2020046543A2/fr not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040186285A1 (en) * | 2003-03-21 | 2004-09-23 | Ceramoptec Industries, Inc. | Water-soluble mono-PEGylated tetrapyrrole derivatives for photodynamic therapy and method of production |
Non-Patent Citations (3)
| Title |
|---|
| KIM ET AL.: "Water-Soluble Porphyrin-Polyethylene Glycol Conjugates with Enhanced Cellular Uptake for Photodynamic Therapy", JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, vol. 9, 2009, pages 7130 - 7135 * |
| LUCIANO, MICHAEL ET AL.: "Modifications of Porphyrins and Hydroporphyrins for Their Solubilization in Aqueous Media", MOLECULES, vol. 22, no. 6, 2017, pages 1 - 47, XP055708111, DOI: 10.3390/molecules22060980 * |
| POTOCNY, ANDREA M. ET AL.: "Electrochemical, Spectroscopic, and 102 Sensitization Characteristics of Synthetically Accessible Linear Tetrapyrrole Complexes of Palladium and Platinum", INORG CHEM., vol. 56, no. 21, 6 November 2017 (2017-11-06), pages 12703 - 12711, XP055708116, DOI: 10.1021/acs.inorgchem.7b00796 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020046543A2 (fr) | 2020-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Imberti et al. | New designs for phototherapeutic transition metal complexes | |
| Hempel et al. | Crosstalk between calcium and reactive oxygen species signaling in cancer | |
| Wu et al. | Recent advances in noble metal complex based photodynamic therapy | |
| Hynek et al. | Porous framework materials for singlet oxygen generation | |
| Dąbrowski et al. | Engineering of relevant photodynamic processes through structural modifications of metallotetrapyrrolic photosensitizers | |
| Shaili | Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments | |
| Stacey et al. | New avenues in the design and potential application of metal complexes for photodynamic therapy | |
| Lazarides et al. | Photocatalytic hydrogen production from a noble metal free system based on a water soluble porphyrin derivative and a cobaloxime catalyst | |
| Therrien | Transporting and Shielding Photosensitisers by Using Water‐Soluble Organometallic Cages: A New Strategy in Drug Delivery and Photodynamic Therapy | |
| Yu et al. | Chemical modification of temoporfin–a second generation photosensitizer activated using upconverting nanoparticles for singlet oxygen generation | |
| Guan et al. | Phosphorescent iridium (III) complexes for anticancer applications | |
| Tovmasyan et al. | Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology | |
| T de Oliveira et al. | Chlorins: natural sources, synthetic developments and main applications | |
| Mehanna et al. | Enhanced cellular uptake and photochemotherapeutic potential of a lipophilic strained Ru (ii) polypyridyl complex | |
| GB2433070A (en) | Porphyrin derivatives and their use in photon activation therapy | |
| Chen et al. | Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru (II) arene complex with dual activities of photobinding and photocleavage toward DNA | |
| MX2014013632A (es) | Compuestos de pirimidina para el tratamiento de cancer. | |
| PH12012500789A1 (en) | Prolyl hydroxylase inhibitors | |
| Cole et al. | Ru (II) phenanthroline-based oligothienyl complexes as phototherapy agents | |
| TW200730532A (en) | Camptothecin derivatives as chemoradiosensitizing agents | |
| Zhou et al. | A novel azopyridine-based Ru (ii) complex with GSH-responsive DNA photobinding ability | |
| Banerjee et al. | Dual-action platinum (II) Schiff base complexes: photocytotoxicity and cellular imaging | |
| Sweigert et al. | Nickel, copper, and zinc centered ruthenium-substituted porphyrins: effect of transition metals on photoinduced DNA cleavage and photoinduced melanoma cell toxicity | |
| WO2006126177A3 (fr) | Derives de 2-indolyl imidazo[4,5-d]phenanthroline et utilisation dans le traitement du cancer | |
| Toupin et al. | Unlocking the Potential of Ru (II) Dual‐action Compounds with the Power of the Heavy‐atom Effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 19854266 Country of ref document: EP Kind code of ref document: A2 |